Do more cardiac rehabilitation visits reduce events compared with fewer visits?

Circulation

Volumn 121, Issue 1, 2010, Pages 8-9

  Weintraub, William S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEART INFARCTION; HEART REHABILITATION; HUMAN; MEDICARE; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK REDUCTION;

APPOINTMENTS AND SCHEDULES; EXERCISE; HEART DISEASES; HUMANS; TREATMENT OUTCOME;

EID: 74549187040     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3181cd3ce6     Document Type: Editorial

References (9)

1. Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of death and myo-cardial infarction among elderly Medicare beneficiaries. Circulation. 2010;121:63-70.
2. Kleinbaum DG, Morgan, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. New York, NY: Van Nostrand Reinhold; 1982:242-280.
3. Weintraub WS, Deaton C, Shaw L, Mahoney E, Morris DC, Saunders C, Canup D, Connolly S, Culler S, Becker ER, Kosinski A, Boccuzzi SJ. Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database? Am J Cardiol. 1999;84:166-169.
4. Hill AB. The environment and disease: association or causation? Proc Roy Soc Med. 1965;58:295-300.
5. Doll R, Hill AB. Smoking and carcinoma of the lung: preliminary report. BMJ. 1950;2:739-748.
6. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits. BMJ. 1954;228:1451-1455.
7. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson Dr, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized trials. Am J Med. 2004;116:682-692.
8. Spertus J. Selecting end points in clinical trials: what evidence do we really need to evaluate a new treatment? Am Heart J. 2001;142:745-747.
9. Mahoney EM, Chu H. Cost-effectiveness analysis alongside clinical trials: statistical and methodologic issues. In: Weintraub WS, ed. Cardiovascular Health Care Economics. Totowa, NJ: Humana Press, Inc; 2003:123-156.